Samuel Heath & Sons Competitors

Samuel Heath & Sons (LON:HSM) and CRH (LON:CRH) are both basic materials companies, but which is the superior business? We will contrast the two companies based on the strength of their analyst recommendations, valuation, earnings, profitability, institutional ownership, risk and dividends.

Dividends

Samuel Heath & Sons pays an annual dividend of GBX 0.06 per share and has a dividend yield of 0.0%. CRH pays an annual dividend of GBX 84 per share and has a dividend yield of 2.4%. Samuel Heath & Sons pays out 0.2% of its earnings in the form of a dividend. CRH pays out 81.5% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future.

Valuation and Earnings

This table compares Samuel Heath & Sons and CRH's gross revenue, earnings per share (EPS) and valuation.

Samuel Heath & Sons is trading at a lower price-to-earnings ratio than CRH, indicating that it is currently the more affordable of the two stocks.

Profitability

This table compares Samuel Heath & Sons and CRH's net margins, return on equity and return on assets.

Analyst Recommendations

This is a breakdown of recent recommendations and price targets for Samuel Heath & Sons and CRH, as reported by MarketBeat.com.

CRH has a consensus price target of GBX 3,600, suggesting a potential upside of 3.30%. Given CRH's higher possible upside, analysts plainly believe CRH is more favorable than Samuel Heath & Sons.

Summary

CRH beats Samuel Heath & Sons on 7 of the 8 factors compared between the two stocks.

Breedon Group (LON:BREE) and Samuel Heath & Sons (LON:HSM) are both small-cap basic materials companies, but which is the better stock? We will compare the two businesses based on the strength of their analyst recommendations, valuation, institutional ownership, risk, profitability, dividends and earnings.

Profitability

This table compares Breedon Group and Samuel Heath & Sons' net margins, return on equity and return on assets.

Analyst Recommendations

This is a summary of recent ratings and recommmendations for Breedon Group and Samuel Heath & Sons, as provided by MarketBeat.com.

Breedon Group currently has a consensus target price of GBX 95.50, suggesting a potential upside of 1.60%. Given Breedon Group's higher possible upside, analysts plainly believe Breedon Group is more favorable than Samuel Heath & Sons.

Earnings and Valuation

This table compares Breedon Group and Samuel Heath & Sons' gross revenue, earnings per share (EPS) and valuation.

Samuel Heath & Sons is trading at a lower price-to-earnings ratio than Breedon Group, indicating that it is currently the more affordable of the two stocks.

Summary

Breedon Group beats Samuel Heath & Sons on 5 of the 6 factors compared between the two stocks.

Ibstock (LON:IBST) and Samuel Heath & Sons (LON:HSM) are both small-cap basic materials companies, but which is the better business? We will compare the two companies based on the strength of their institutional ownership, analyst recommendations, profitability, risk, valuation, dividends and earnings.

Analyst Ratings

This is a breakdown of recent ratings for Ibstock and Samuel Heath & Sons, as provided by MarketBeat.

Ibstock presently has a consensus price target of GBX 206.50, indicating a potential downside of 10.22%. Given Ibstock's higher probable upside, research analysts plainly believe Ibstock is more favorable than Samuel Heath & Sons.

Valuation & Earnings

This table compares Ibstock and Samuel Heath & Sons' gross revenue, earnings per share (EPS) and valuation.

Ibstock is trading at a lower price-to-earnings ratio than Samuel Heath & Sons, indicating that it is currently the more affordable of the two stocks.

Profitability

This table compares Ibstock and Samuel Heath & Sons' net margins, return on equity and return on assets.

Summary

Ibstock beats Samuel Heath & Sons on 4 of the 6 factors compared between the two stocks.

Volution Group (LON:FAN) and Samuel Heath & Sons (LON:HSM) are both small-cap basic materials companies, but which is the better business? We will compare the two companies based on the strength of their institutional ownership, analyst recommendations, profitability, risk, valuation, dividends and earnings.

Profitability

This table compares Volution Group and Samuel Heath & Sons' net margins, return on equity and return on assets.

Valuation & Earnings

This table compares Volution Group and Samuel Heath & Sons' gross revenue, earnings per share (EPS) and valuation.

Samuel Heath & Sons is trading at a lower price-to-earnings ratio than Volution Group, indicating that it is currently the more affordable of the two stocks.

Analyst Ratings

This is a breakdown of recent ratings for Volution Group and Samuel Heath & Sons, as provided by MarketBeat.

Volution Group presently has a consensus price target of GBX 410, indicating a potential downside of 1.44%. Given Volution Group's higher probable upside, research analysts plainly believe Volution Group is more favorable than Samuel Heath & Sons.

Summary

Volution Group beats Samuel Heath & Sons on 5 of the 6 factors compared between the two stocks.

Samuel Heath & Sons (LON:HSM) and Tyman (LON:TYMN) are both small-cap basic materials companies, but which is the better investment? We will compare the two businesses based on the strength of their analyst recommendations, earnings, risk, dividends, profitability, institutional ownership and valuation.

Analyst Ratings

This is a summary of recent ratings and target prices for Samuel Heath & Sons and Tyman, as reported by MarketBeat.

Tyman has a consensus target price of GBX 315, indicating a potential downside of 21.54%. Given Tyman's higher possible upside, analysts clearly believe Tyman is more favorable than Samuel Heath & Sons.

Profitability

This table compares Samuel Heath & Sons and Tyman's net margins, return on equity and return on assets.

Valuation & Earnings

This table compares Samuel Heath & Sons and Tyman's revenue, earnings per share and valuation.

Samuel Heath & Sons is trading at a lower price-to-earnings ratio than Tyman, indicating that it is currently the more affordable of the two stocks.

Summary

Tyman beats Samuel Heath & Sons on 5 of the 6 factors compared between the two stocks.

Forterra (LON:FORT) and Samuel Heath & Sons (LON:HSM) are both small-cap basic materials companies, but which is the better investment? We will contrast the two businesses based on the strength of their profitability, risk, earnings, valuation, analyst recommendations, dividends and institutional ownership.

Earnings and Valuation

This table compares Forterra and Samuel Heath & Sons' top-line revenue, earnings per share and valuation.

Forterra is trading at a lower price-to-earnings ratio than Samuel Heath & Sons, indicating that it is currently the more affordable of the two stocks.

Analyst Recommendations

This is a summary of current recommendations and price targets for Forterra and Samuel Heath & Sons, as provided by MarketBeat.com.

Forterra currently has a consensus target price of GBX 219.67, suggesting a potential downside of 25.54%. Given Forterra's higher possible upside, equities analysts plainly believe Forterra is more favorable than Samuel Heath & Sons.

Profitability

This table compares Forterra and Samuel Heath & Sons' net margins, return on equity and return on assets.

Summary

Forterra beats Samuel Heath & Sons on 4 of the 6 factors compared between the two stocks.